CD4+25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation

American Journal of Transplantation

Volumn 6, Issue 8, 2006, Pages 1799-1808

  Bharat, A ^a   Fields, R C ^a   Steward, N ^a   Trulock, E P ^a   Patterson, G A ^a   Mohanakumar, T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Bronchiolitis obliterans; Collagen type V; IL 10; Lung transplant; Regulatory T cells

Indexed keywords

COLLAGEN TYPE 5; INTERLEUKIN 10;

ADULT; ARTICLE; AUTOIMMUNITY; BRONCHIOLITIS OBLITERANS; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; IMMUNOGENICITY; LUNG GRAFT REJECTION; LUNG PARENCHYMA; LUNG TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

AUTOIMMUNITY; BRONCHIOLITIS OBLITERANS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN TYPE V; FEMALE; HUMANS; INTERFERON TYPE II; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; TH1 CELLS;

EID: 33745778016     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01383.x     Document Type: Article

References (55)

1. Reznik SI, Jaramillo A, Zhang L, Patterson GA, Cooper JD, Mohanakumar T. Anti-HLA antibody binding to hla class I molecules induces proliferation of airway epithelial cells: A potential mechanism for bronchiolitis obliterans syndrome. J Thorac Cardiovasc Surg 2000; 119: 39-45.
2. Boehler A, Kesten S, Weder W, Speich R. Bronchiolitis obliterans after lung transplantation: A review. Chest 1998; 114: 1411-1426.
3. Reznik SI, Jaramillo A, SivaSai KS et al. Indirect allorecognition of mismatched donor HLA class II peptides in lung transplant recipients with bronchiolitis obliterans syndrome. Am J Transplant 2001; 1: 228-235.
4. Valentine VG, Robbins RC, Berry GJ, Patel HR, Reichenspurner H, Reitz BA et al. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant 1996; 15: 371-383.
5. Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M et al. Bronchiolitis obliterans syndrome 2001: An update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297-310.
6. Lu KC, Jaramillo A, Mendeloff EN et al. Concomitant allorecognition of mismatched donor HLA class I- and class II-derived peptides in pediatric lung transplant recipients with bronchiolitis obliterans syndrome. J Heart Lung Transplant 2003; 22: 35-43.
7. Jaramillo A, Smith MA, Phelan D et al. Development of ELISA-detected anti-HLA antibodies precedes the development of bronchiolitis obliterans syndrome and correlates with progressive decline in pulmonary function after lung transplantation. Transplantation 1999; 67: 1155-1161.
8. Halloran PF, Homik J, Goes N et al. The "injury response": A concept linking nonspecific injury, acute rejection, and long-term transplant outcomes. Transplant Proc 1997; 29: 79-81.
9. Birk OS, Gur SL, Elias D et al. The 60-kDa heat shock protein modulates allograft rejection. Proc Natl Acad Sci USA 1999; 96: 5159-5163.
10. Fedoseyeva EV, Zhang F, Orr PL, Levin D, Buncke HJ, Benichou G. De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process. J Immunol 1999; 162: 6836-6842.
11. Koenen HJ, Fasse E, Joosten I. IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression. J Immunol 2003; 171: 6431-6441.
12. Barber LD, Whitelegg A, Madrigal JA, Banner NR, Rose ML. Detection of vimentin-specific autoreactive CD8+ T cells in cardiac transplant patients. Transplantation 2004; 77: 1604-1609.
13. Haque MA, Mizobuchi T, Yasufuku K et al. Evidence for immune responses to a self-antigen in lung transplantation: Role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J Immunol 2002; 169: 1542-1549.
14. Yasufuku K, Heidler KM, Woods KA et al. Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance. Transplantation 2002; 73: 500-505.
15. Schlesinger C, Meyer CA, Veeraraghavan S, Koss MN. Constrictive (obliterative) bronchiolitis: Diagnosis, etiology, and a critical review of the literature. Ann Diagn Pathol 1998; 2: 321-334.
16. Shaw RJ, Djukanovic R, Tashkin DP, Millar AB, du Bois RM, Orr PA. The role of small airways in lung disease. Respir Med 2002; 96: 67-80.
17. Veloso FT, Rodrigues H, Aguiar MM. Bronchiolitis obliterans in ulcerative colitis. J Clin Gastroenterol 1994; 19: 339-341.
18. Cantu E, 3rd, Appel JZ, 3rd, Hartwig MG et al. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg 2004; 78: 1142-1151; discussion 1142-1151.
19. Davis RD, Jr., Lau CL, Eubanks S et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003; 125: 533-542.
20. Ciubotariu R, Colovai AI, Pennesi G et al. Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28-regulatory T cells. J Immunol 1998; 161: 5193-5202.
21. Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993; 11: 729-766.
22. Sakaguchi S, Sakaguchi N, Shimizu J et al. Immunologic tolerance maintained by CD25+CD4+regulatory T cells: Their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 2001; 182: 18-32.
23. Jaramillo A, Majumder K, Manna PP et al. Identification of HLA-A3-restricted CD8+ T cell epitopes derived from mammaglobin-A, a tumor-associated antigen of human breast cancer. Int J Cancer 2002; 102: 499-506.
24. Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH. Infectious tolerance: Human CD25(+) regulatory T cells convey suppressor activity to conventional CD4(+) T helper cells. J Exp Med 2002; 196: 255-260.
25. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev 2001; 182: 68-79.
26. Groux H. Type 1 T-regulatory cells: Their role in the control of immune responses. Transplantation 2003; 75 (9 Suppl): 8S-12S.
27. Boehler A, Bai XH, Liu M et al. Upregulation of T-helper 1 cytokines and chemokine expression in post-transplant airway obliteration. Am J Respir Crit Care Med 1999; 159: 1910-1917.
28. Ross DJ, Moudgil A, Bagga A et al. Lung allograft dysfunction correlates with gamma-interferon gene expression in bronchoalveolar lavage. J Heart Lung Transplant 1999; 18: 627-636.
29. Strom TB, Roy-Chaudhury P, Manfro R et al. The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 1996; 8: 688-693.
30. Sundaresan S, Alevy YG, Steward N et al. Cytokine gene transcripts for tumor necrosis factor-alpha, interleukin-2, and interferon-gamma in human pulmonary allografts. J Heart Lung Transplant 1995; 14: 512-518.
31. Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G. Human CD4(+)CD25(+) regulatory, contact-dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]. J Exp Med 2002; 196: 247-253.
32. Levings MK, Sangregorio R, Roncarolo MG. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001; 193: 1295-1302.
33. Shevach EM. CD4+ CD25+ suppressor T cells: More questions than answers. Nat Rev Immunol 2002; 2: 389-400.
34. Jaramillo A, Fernandez FG, Kuo EY, Trulock EP, Patterson GA, Mohanakumar T. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation. Pediatr Transplant 2005; 9: 84-93.
35. Joosten SA, van Dixhoorn MG, Borrias MC et al. Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat. Am J Pathol 2002; 160: 1301-1310.
36. van Kuppevelt TH, Veerkamp JH, Timmermans JA. Immunoquantification of type I, III, IV and V collagen in small samples of human lung parenchyma. Int J Biochem Cell Biol 1995; 27: 775-782.
37. Madri JA, Furthmayr H. Collagen polymorphism in the lung. An immunochemical study of pulmonary fibrosis. Hum Pathol 1980; 11: 353-366.
38. Hoshino M, Nakamura Y, Sim J, Shimojo J, Isogai S. Bronchial subepithelial fibrosis and expression of matrix metalloproteinase-9 in asthmatic airway inflammation. J Allergy Clin Immunol 1998; 102: 783-788.
39. Adachi E, Hopkinson I, Hayashi T. Basement-membrane stromal relationships: Interactions between collagen fibrils and the lamina densa. Int Rev Cytol 1997; 173: 73-156.
40. Linsenmayer TF, Fitch JM, Birk DE. Heterotypic collagen fibrils and stabilizing collagens. Controlling elements in corneal morphogenesis. Ann N Y Acad Sci 1990; 580: 143-160.
41. Lauer-Fields JL, Sritharan T, Stack MS, Nagase H, Fields GB. Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9. J Biol Chem 2003; 278: 18140-18145.
42. Trello CA, Williams DA, Keller CA, Crim C, Webster RO, Ohar JA. Increased gelatinolytic activity in bronchoalveolar lavage fluid in stable lung transplant recipients. Am J Respir Crit Care Med 1997; 156: 1978-1986.
43. Hubner RH, Meffert S, Mundt U et al. Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation. Eur Respir J 2005; 25: 494-501.
44. Wilkes DS, Heidler KM, Yasufuku K et al. Cell-mediated immunity to collagen V in lung transplant recipients: Correlation with collagen V release into BAL fluid. J Heart Lung Transplant 2001; 20: 167.
45. Liu Z, Colovai AI, Tugulea S et al. Indirect recognition of donor HLA-DR peptides in organ allograft rejection. J Clin Invest 1996; 98: 1150-1157.
46. Clayton JP, Gammon GM, Ando DG, Kono DH, Hood L, Sercarz EE. Peptide-specific prevention of experimental allergic encephalomyelitis. Neonatal tolerance induced to the dominant T cell determinant of myelin basic protein. J Exp Med 1989; 169: 1681-1691.
47. Burlingham WJ, Haynes L, Jankowska-Gan E et al. Correlation of Bronchiolitis Obliterans Syndrome (BOS) with Autoimmunity to collagen (V) after lung transplantation. In: ATC annual meeting 2003. Washington, DC, 2003.
48. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 2005; 6: 345-352.
49. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190: 995-1004.
50. Jaramillo A, Narayanan K, Campbell L et al. Lack of chronic lung allograft rejection is associated with expansion of regulatory CD4+CD25+T-cells and a predominant Th2 alloreactivity. In: ASHI 30th Annual Meeting. San Antonio, Texas: American Society for Histocompatibility and Immunogenetics, 2004.
51. Huss R. In vitro determination of self-reactivity in the early postcyclosporine period. Transpl Immunol 1993; 1: 228-234.
52. Sakaguchi S, Sakaguchi N. Thymus and autoimmunity. Transplantation of the thymus from cyclosporin A-treated mice causes organ-specific autoimmune disease in athymic nude mice. J Exp Med 1988; 167: 1479-1485.
53. Sakaguchi S, Sakaguchi N. Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. V. Neonatal administration of cyclosporin A causes autoimmune disease. J Immunol 1989; 142: 471-480.
54. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001; 167: 1945-1953.
55. Battaglia M, Stabilini A, Roncarolo MG. Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. Blood 2005; 105: 4743-4748.